| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9391301 | Journal of Vascular and Interventional Radiology | 2005 | 11 Pages |
Abstract
TheraSphere administration appears to provide stabilization of liver disease with minimal toxicity in patients in whom standard systemic chemotherapy regimens have failed.
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
![90Y Microsphere (TheraSphere) Treatment for Unresectable Colorectal Cancer Metastases of the Liver: Response to Treatment at Targeted Doses of 135-150 Gy as Measured by [18F]Fluorodeoxyglucose Positron Emission Tomography and Computed Tomographic Imaging](/preview/png/9391301.png "First Page Preview: 90Y Microsphere (TheraSphere) Treatment for Unresectable Colorectal Cancer Metastases of the Liver: Response to Treatment at Targeted Doses of 135-150 Gy as Measured by [18F]Fluorodeoxyglucose Positron Emission Tomography and Computed Tomographic Imaging")
Authors
Robert J. MD, Kenneth G. MA, James E. PhD, Ching-Yee O. MD, PhD, Vanessa L. MS, Mark Van MS, Jean-Francois H. MD, Riad MD, MBA,